J. Tracy
University of Vermont, VT·Public Health & Epidemiology
Cervical cancer can be prevented almost entirely, yet it remains the fourth most common cancer in women worldwide. More than 80% of cases occur in low- and middle-income countries.
- Fields
Public Health & Epidemiology
Medicine & Clinical Research
Social Science
- Topics
cervical cancer
human papillomavirus
cervical screening
- Grants
- 1 known grant, through Aug 2027
What they work on
- Explain how INSPIRE's stakeholder-engaged activities led to rapid scale-up of HPV testing in the Peruvian Amazon, using a realist evaluation of the people involved.
- Translate the INSPIRE methodology into ASSIST, a general implementation strategy, and build a toolkit for stakeholder-engaged planning and adaptation to local context.
- Test ASSIST's effect on cervical screening coverage and follow-up care during Peru's national HPV scale-up, using an interrupted time series design and the extended RE-AIM framework.
- Identify local factors that shape ASSIST's success through a qualitative comparative case study across implementation sites.
More about the research
Tests for HPV (human papillomavirus, the virus that causes most cervical cancer) already exist. What is often missing is a way for health systems to adopt these tests and keep them running. This project studies how to move proven screening technology into routine care, a field called implementation science.
Why it matters
Low- and middle-income countries carry most of the cervical cancer burden even though effective HPV testing exists. A tested, adaptable strategy and toolkit could help ministries of health plan HPV screening and follow-up care around their own resources and values. This could expand screening coverage for women and inform how other complex health programs are scaled up and sustained.
Known grants
From NIH and NSF research grants. Labs often have other funding we can't see.
Closest labs
Jean Hunleth
Washington University in St Louis, MO·Public Health & Epidemiology
Identify barriers and facilitators at multiple levels that shape HPV vaccination and primary cervical cancer prevention in rural, urban and peri-urban adolescent HIV clinics in Zambia.
D. Moon
Tulane University of Louisiana, LA·Public Health & Epidemiology
Test implementation best practices for a Screen & Treat program that uses self-collected HPV DNA testing, delivered within HIV care and treatment services at selected health facilities in Mozambique.
Elizabeth Keating
University of Utah, UT·Medicine & Clinical Research·Early-career
Describe barriers to care for injured children at health centers and district hospitals in Tanzania, the first level of medical contact, using a mixed methods approach.
The school
University of Vermont: 16 labs on PI Pages, $246M a year on research, 76 research doctorates a year.
Reach out
A start for your email. Fill in the brackets.